Trial Profile
The Role of Vasopressin Antagonism on Renal Sodium Handling
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary) ; Sodium chloride
- Indications Ascites; Autosomal dominant polycystic kidney disease; Benign prostatic hyperplasia; Cardiac oedema; Cystinuria; Heart failure; Hyponatraemia; Oedema; Renal failure
- Focus Pharmacodynamics
- 19 Apr 2017 New trial record
- 04 Apr 2017 Results presented at The 99th Annual Meeting of the Endocrine Society